SNRS- Sunrise Technologies Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies

SNRS 0.000001000

0.0%

Jun 6 11:01 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Loren who wrote (1532)	8/19/1998 12:11:00 PM
From: Sylvester	of 4140

Love it when you guys Rainer & Loren talk dirty. Good job!! Haven't bugged my optho sources in a while wo I made a few calls. Some sold shares at $8 last week but really no significant volume. Would buy again at $6.25. What's missing is all this new volume based on the NASDAQ listing. Probably the earning report took the steam out of the possibilities. I might have mentioned that a friend of mine writes an analysis program for a large brokerage. No one programmer writes enough of the program to see how it works but all know more or less the intent. Basically, the program signals buying opportunities for institutional investors and mutual funds. If their determination echo those of Rainer and Loren, and I see no reason why they would not, don't expect to see the volume we're looking for. This same friend, who owns SNRS at $5.50 or so, likes the stock long term in theory but suggests waiting until volume picks up on the upside (easy call) and the stock breaks through $8.50, a long way off. The stock should back off at this point but volume will remain strong as timed accumulation moves the stock up slowly towards the promised land. When? Not that soon. General tension about which way the market in general is heading keeps SNRS down. Except for info on the progress of the trials, there is no new big news scheduled for a while. He tells me that large investors don't mind getting in late, and it's unwise to purchase a small issue in high volume untill overall volume over several days in 40% higher than the average volume thus far. This combined with a very narrow daily trading range are two of the criteria needed for a buying signal. He says there are 170 others in all in the program, but only someone on the inside of the mutual fund weights how each criteria is prioritized. The only funds he thinks may buy SNRS soon are biotech funds needing to exchange one stock for another. In this situation, a pending FDA approval combined with market potential are highly weighted criteria. In general the charts may be indicating that we'll be a long time languishing between just above $6 and just below $8 where traders may make some money but others may just exit the stock for a while and take advantage of more current opportunities. I for one, am sitting but admit it's becomming more uncomfortable in the short and now mid term. Any opinions?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next